NEW YORK (TheStreet) -- CHANGE IN RATINGS

Align Technology

(ALGN) - Get Report

was downgraded at Jefferies to hold from buy. Valuation call, based on a $38 price target, Jefferies said.

Artisan Partners Asset Management

(APAM) - Get Report

was downgraded at Citigroup to neutral. Stock has appreciated 65% since its March 7 IPO, Citi said.

Credit Suisse

(CS) - Get Report

was upgraded to hold at TheStreet Ratings.

Enersis

(ENI)

was downgraded to hold at TheStreet Ratings.

Exelon

(EXC) - Get Report

was downgraded at Deutsche Bank to hold from buy. $34 price target. Company faces significant long-term headwinds, Deutsche Bank said.

Also see: Big Pharma Wants Fish Oil After All, but at Half Amarin's Selling Price >>

FirstEnergy

(FE) - Get Report

was downgraded at Credit Suisse to neutral from outperform. $40 price target. Outlook for a recovery has been delayed, Credit Suisse said.

W. R. Grace

(GRA) - Get Report

was initiated with a buy rating at Goldman Sachs. The company will benefit from a construction market recovery and its emergence from Chapter 11, Goldman said. Price target is $105.

Intelsat

(I) - Get Report

was initiated with a buy rating at UBS. The company operates in a defensive sector and will see equity appreciation as debt is paid down, UBS said. Price target is $30.

Johnson Controls

(JCI) - Get Report

was upgraded at Wells Fargo to outperform from market perform. Tide has started to turn for the company, which could exceed 2014 earnings estimates, Wells Fargo said.

Also see: Top Insider Trades: GHDX, MO, NHF, FES >>

Kansas City Southern

(KSU) - Get Report

was upgraded at BMO Capital to market perform from underperform. A recovery in ag and coal volumes coupled with strong trends in intermodal and auto drive the upgrade, BMO said. Price target goes to $107.

Eli Lilly

(LLY) - Get Report

was upgraded at Jefferies to hold from underperform. Valuation call, based on a $49 price target, Jefferies said.

Merck

(MRK) - Get Report

was upgraded at Jefferies to buy from hold. $54 price target. Stock is attractive, based on a sum-of-the-parts valuation, Jefferies said.

Public Service

(PEG) - Get Report

was upgraded at Credit Suisse to neutral from underperform. $31.50 price target. Stock does not deserve to trade at such a discount to its peers, Credit Suisse said.

St. Jude Medical

(STJ)

was downgraded at Canaccord Genuity to sell from hold. $35 price target. Earnings quality is declining and the company is facing increased competition, Canaccord said.

Taminco

(TAM)

was initiated with a buy at UBS. Change made because of company's deleveraging and growth prospects, said UBS. Price target is $21.

Taminco was initiated with a buy rating at Goldman Sachs. $22 price target. Company has an attractive niche and solid finances, Goldman said.

Texas Instruments

(TXN) - Get Report

was upgraded at Drexel Hamilton to buy from hold. $40 price target. Inventory is low, distributor turns are rising and end-market demand is firming, Drexel Hamilton said.

Also see: Home Price Gains to Slow >>

URS

(URS)

was downgraded at FBR Capital Markets to market perform from outperform. Valuation call, based on a $45 price target, FBR Capital Markets said.

STOCK COMMENTS / EPS CHANGES

Allergan

(AGN) - Get Report

was added to the US 1 List at Bank of America/Merrill Lynch. Stock is attractive, following a 14% pullback this month, BofA/Merrill said. $110 price target.

C.H. Robinson Worldwide

(CHRW) - Get Report

price target and estimates were raised at Citigroup. Margin compression from the Phoenix/Global Forwarding business combination should lessen in the second and third quarters, said Citigroup. Price target goes to $59.

FedEx

(FDX) - Get Report

estimates were reduced at Wells Fargo through 2014. Secular growth headwinds remain, Wells said. Market Perform rating.

Foot Locker

(FL) - Get Report

estimates were raised at UBS. Earnings estimates were increased to reflect a favorable shift of revenue into the second quarter despite the slow start to May, said UBS.

Procter & Gamble

(PG) - Get Report

target was raised at Credit Suisse. Shares are now seen reaching $85. A.G. Lafley's return will likely add a premium to the stock, Credit Suisse said.

>To submit a news tip, email:

tips@thestreet.com

.

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.